ROCK signaling mediates the adoption of different modes of migration and invasion in human mammary epithelial tumor cells

Experimental Cell Research

Volumn 312, Issue 19, 2006, Pages 3857-3871

  Torka, Robert ^a   Thuma, Florian ^a   Herzog, Volker ^a   Kirfel, Gregor ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Breast cancer; Invasion; Migration; MMP; ROCK

Indexed keywords

COFILIN; MYOSIN LIGHT CHAIN KINASE; RHO KINASE;

ARTICLE; BREAST EPITHELIUM; CANCER INVASION; CELL ADHESION; CELL ASSAY; CELL MIGRATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; LAMELLIPODIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 33750289641     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.08.025     Document Type: Article

References (73)

1. Weigelt B., Peterse J.L., and van 't Veer L.J. Breast cancer metastasis: markers and models. Nat. Rev., Cancer 5 (2005) 591-602
2. Lauffenburger D.A., and Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 84 (1996) 359-369
3. Sheetz M.P., Felsenfeld D., Galbraith C.G., and Choquet D. Cell migration as a five-step cycle. Biochem. Soc. Symp. 65 (1999) 233-243
4. Borm B., Requardt R.P., Herzog V., and Kirfel G. Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization. Exp. Cell Res. 302 (2005) 83-95
5. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev., Cancer 2 (2002) 161-174
6. Hood J.D., and Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev., Cancer 2 (2002) 91-100
7. Nobes C.D., and Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144 (1999) 1235-1244
8. Sahai E., and Marshall C.J. RHO-GTPases and cancer. Nat. Rev., Cancer 2 (2002) 133-142
9. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
10. Raftopoulou M., and Hall A. Cell migration: Rho GTPases lead the way. Dev. Biol. 265 (2004) 23-32
11. Zaidel-Bar R., Cohen M., Addadi L., and Geiger B. Hierarchical assembly of cell-matrix adhesion complexes. Biochem. Soc. Trans. 32 (2004) 416-420
12. DeMali K.A., and Burridge K. Coupling membrane protrusion and cell adhesion. J. Cell Sci. 116 (2003) 2389-2397
13. Burridge K., and Wennerberg K. Rho and Rac take center stage. Cell 116 (2004) 167-179
14. DiMilla P.A., Stone J.A., Quinn J.A., Albelda S.M., and Lauffenburger D.A. Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J. Cell Biol. 122 (1993) 729-737
15. Palecek S.P., Huttenlocher A., Horwitz A.F., and Lauffenburger D.A. Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J. Cell Sci. 111 Pt. 7 (1998) 929-940
16. Cox E.A., Sastry S.K., and Huttenlocher A. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol. Biol. Cell 12 (2001) 265-277
17. Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev., Cancer 3 (2003) 362-374
18. Wolf K., Mazo I., Leung H., Engelke K., vonAndrian U.H., Deryugina E.I., Strongin A.Y., Brocker E.B., and Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160 (2003) 267-277
19. Sahai E., and Marshall C.J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5 (2003) 711-719
20. Webb D.J., and Horwitz A.F. New dimensions in cell migration. Nat. Cell Biol. 5 (2003) 690-692
21. Hojilla C.V., Mohammed F.F., and Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br. J. Cancer 89 (2003) 1817-1821
22. Hinz B., Alt W., Johnen C., Herzog V., and Kaiser H.W. Quantifying lamella dynamics of cultured cells by SACED, a new computer-assisted motion analysis. Exp. Cell Res. 251 (1999) 234-243
23. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., and McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47 (1987) 3239-3245
24. Svitkina T.M., Shevelev A.A., Bershadsky A.D., and Gelfand V.I. Cytoskeleton of mouse embryo fibroblasts. Electron microscopy of platinum replicas. Eur. J. Cell Biol. 34 (1984) 64-74
25. Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R., Noonan D.M., Natali P.G., and Albini A. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87 (2000) 336-3342
26. Lacroix M., and Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83 (2004) 249-289
27. Bachmeier B.E., Nerlich A.G., Lichtinghagen R., and Sommerhoff C.P. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res. 21 (2001) 3821-3828
28. Ishibashi O., Mori Y., Kurokawa T., and Kumegawa M. Breast cancer cells express cathepsins B and L but not cathepsins K or H. Cancer Biochem. Biophys. 17 (1999) 69-78
29. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15 (2003) 740-746
30. Wilkinson S., Paterson H.F., and Marshall C.J. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 7 (2005) 255-261
31. Wang W., Wyckoff J.B., Frohlich V.C., Oleynikov Y., Huttelmaier S., Zavadil J., Cermak L., Bottinger E.P., Singer R.H., White J.G., Segall J.E., and Condeelis J.S. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res. 62 (2002) 6278-6288
32. Wyckoff J.B., Jones J.G., Condeelis J.S., and Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60 (2000) 2504-2511
33. Itoh K., Yoshioka K., Akedo H., Uehata M., Ishizaki T., and Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5 (1999) 221-225
34. Takamura M., Sakamoto M., Genda T., Ichida T., Asakura H., and Hirohashi S. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 33 (2001) 577-581
35. Keely P.J., Westwick J.K., Whitehead I.P., Der C.J., and Parise L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390 (1997) 632-636
36. van Golen K.L., Bao L., DiVito M.M., Wu Z., Prendergast G.C., and Merajver S.D. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Mol. Cancer Ther. 1 (2002) 575-583
37. Kim M.S., Lee E.J., Kim H.R., and Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63 (2003) 5454-5461
38. Chen B.H., Tzen J.T., Bresnick A.R., and Chen H.C. Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. J. Biol. Chem. 277 (2002) 33857-33863
39. Jeong H.W., Nam J.O., and Kim I.S. The COOH-terminal end of R-Ras alters the motility and morphology of breast epithelial cells through Rho/Rho-kinase. Cancer Res. 65 (2005) 507-515
40. Beningo K.A., Dembo M., Kaverina I., Small J.V., and Wang Y.L. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J. Cell Biol. 153 (2001) 881-888
41. Subauste M.C., Pertz O., Adamson E.D., Turner C.E., Junger S., and Hahn K.M. Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165 (2004) 371-381
42. Iwasaki T., Nakata A., Mukai M., Shinkai K., Yano H., Sabe H., Schaefer E., Tatsuta M., Tsujimura T., Terada N., Kakishita E., and Akedo H. Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration. Int. J. Cancer 97 (2002) 330-335
43. Tsubouchi A., Sakakura J., Yagi R., Mazaki Y., Schaefer E., Yano H., and Sabe H. Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol. 159 (2002) 673-683
44. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev., Mol. Cell Biol. 6 (2005) 56-68
45. Hsia D.A., Mitra S.K., Hauck C.R., Streblow D.N., Nelson J.A., Ilic D., Huang S., Li E., Nemerow G.R., Leng J., Spencer K.S., Cheresh D.A., and Schlaepfer D.D. Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160 (2003) 753-767
46. Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., and Horwitz A.F. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6 (2004) 154-161
47. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116 (2003) 1409-1416
48. Ridley A.J. Rho GTPases and cell migration. J. Cell Sci. 114 (2001) 2713-2722
49. Leung T., Chen X.Q., Manser E., and Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16 (1996) 5313-5327
50. Amano M., Chihara K., Kimura K., Fukata Y., Nakamura N., Matsuura Y., and Kaibuchi K. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275 (1997) 1308-1311
51. Fukata Y., Oshiro N., Kinoshita N., Kawano Y., Matsuoka Y., Bennett V., Matsuura Y., and Kaibuchi K. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J. Cell Biol. 145 (1999) 347-361
52. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996) 245-248
53. Worthylake R.A., Lemoine S., Watson J.M., and Burridge K. RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol. 154 (2001) 147-160
54. Yasui Y., Amano M., Nagata K., Inagaki N., Nakamura H., Saya H., Kaibuchi K., and Inagaki M. Roles of Rho-associated kinase in cytokinesis; mutations in Rho-associated kinase phosphorylation sites impair cytokinetic segregation of glial filaments. J. Cell Biol. 143 (1998) 1249-1258
55. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev., Mol. Cell Biol. 4 (2003) 446-456
56. Kleer C.G., van Golen K.L., Zhang Y., Wu Z.F., Rubin M.A., and Merajver S.D. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160 (2002) 579-584
57. Kamai T., Tsujii T., Arai K., Takagi K., Asami H., Ito Y., and Oshima H. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9 (2003) 2632-2641
58. Horiuchi A., Imai T., Wang C., Ohira S., Feng Y., Nikaido T., and Konishi I. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 83 (2003) 861-870
59. Shikada Y., Yoshino I., Okamoto T., Fukuyama S., Kameyama T., and Maehara Y. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin. Cancer Res. 9 (2003) 5282-5286
60. Wang W., Yang L.Y., Yang Z.L., Huang G.W., and Lu W.Q. Expression and significance of RhoC gene in hepatocellular carcinoma. World J. Gastroenterol. 9 (2003) 1950-1953
61. Sahai E. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15 (2005) 87-96
62. Wang W., Goswami S., Lapidus K., Wells A.L., Wyckoff J.B., Sahai E., Singer R.H., Segall J.E., and Condeelis J.S. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 64 (2004) 8585-8594
63. Wang W., Goswami S., Sahai E., Wyckoff J.B., Segall J.E., and Condeelis J.S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol. 15 (2005) 138-145
64. Zhou J., Zhao L.Q., Xiong M.M., Wang X.Q., Yang G.R., Qiu Z.L., Wu M., and Liu Z.H. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J. Gastroenterol. 9 (2003) 9-15
65. Kamai T., Arai K., Sumi S., Tsujii T., Honda M., Yamanishi T., and Yoshida K.I. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int. 89 (2002) 449-453
66. Kaneko K., Satoh K., Masamune A., Satoh A., and Shimosegawa T. Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas 24 (2002) 251-257
67. Totsukawa G., Yamakita Y., Yamashiro S., Hartshorne D.J., Sasaki Y., and Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J. Cell Biol. 150 (2000) 797-806
68. Totsukawa G., Wu Y., Sasaki Y., Hartshorne D.J., Yamakita Y., Yamashiro S., and Matsumura F. Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J. Cell Biol. 164 (2004) 427-439
69. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285 (1999) 895-898
70. Sumi T., Matsumoto K., and Nakamura T. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J. Biol. Chem. 276 (2001) 670-676
71. Danen E.H., van Rheenen J., Franken W., Huveneers S., Sonneveld P., Jalink K., and Sonnenberg A. Integrins control motile strategy through a Rho-cofilin pathway. J. Cell Biol. 169 (2005) 515-526
72. Hidalgo M., and Eckhardt S.G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. 93 (2001) 178-193
73. Overall C.M., and Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev., Cancer 2 (2002) 657-672